Related Articles
Metformin attenuates angiotensin II‑induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway
Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway
Luteolin suppresses lipopolysaccharide‑induced cardiomyocyte hypertrophy and autophagy in vitro
Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism
TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling